Cargando…

Role of Corticosteroids in Drug-Induced Liver Injury. A Systematic Review

Introduction: Apart from cessation of the implicated agent leading to drug-induced liver injury (DILI), there is no standard therapy for DILI. Corticosteroids have been used in DILI, although their efficacy is unclear. Published data showed either beneficial effects or no improvement associated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Björnsson, Einar S., Vucic, Vesna, Stirnimann, Guido, Robles-Díaz, Mercedes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867035/ https://www.ncbi.nlm.nih.gov/pubmed/35222034 http://dx.doi.org/10.3389/fphar.2022.820724

Ejemplares similares

Role of Ursodeoxycholic Acid in Treating and Preventing Idiosyncratic Drug-Induced Liver Injury. A Systematic Review
por: Robles-Díaz, Mercedes, et al.
Publicado: (2021)

Editorial: Therapeutic strategies for drug-induced liver injury: Review of the current literature
por: Robles-Díaz, Mercedes, et al.
Publicado: (2022)

N-Acetylcysteine for the Management of Non-Acetaminophen Drug-Induced Liver Injury in Adults: A Systematic Review
por: Sanabria-Cabrera, Judith, et al.
Publicado: (2022)

A new framework for advancing in drug‐induced liver injury research. The Prospective European DILI Registry
por: Björnsson, Einar S., et al.
Publicado: (2022)

Novel Therapies for the Treatment of Drug-Induced Liver Injury: A Systematic Review
por: Benić, Mirjana Stanić, et al.
Publicado: (2022)

Herb-Induced Liver Injury by Ayurvedic Ashwagandha as Assessed for Causality by the Updated RUCAM: An Emerging Cause
por: Bokan, Goran, et al.
Publicado: (2023)

Clinical management of patients with drug‐induced liver injury (DILI)
por: Björnsson, Einar S.
Publicado: (2021)

Biologic and Checkpoint Inhibitor‐Induced Liver Injury: A Systematic Literature Review
por: Shah, Parth, et al.
Publicado: (2020)

Pharmacotherapies for Drug-Induced Liver Injury: A Current Literature Review
por: Li, Meng, et al.
Publicado: (2022)

Research Progress of Pharmacogenomics in Drug-Induced Liver Injury
por: Shao, Qihui, et al.
Publicado: (2021)

Checkpoint inhibitor-induced hepatotoxicity: Role of liver biopsy and management approach
por: Bessone, Fernando, et al.
Publicado: (2022)

The role of antenatal corticosteroids in twin pregnancy
por: Zhu, Jie, et al.
Publicado: (2023)

Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation
por: Meunier, Lucy, et al.
Publicado: (2019)

Chronic Drug-Induced Liver Injury: Updates and Future Challenges
por: Wang, Qiaoling, et al.
Publicado: (2021)

Nutritional Challenges in Patients with Advanced Liver Cirrhosis
por: Stirnimann, Jessica, et al.
Publicado: (2019)

Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury
por: Zhou, Yitian, et al.
Publicado: (2019)

Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans
por: Ravindra, Kodihalli C., et al.
Publicado: (2023)

Genetic variations in drug-induced liver injury (DILI): resolving the puzzle
por: Stephens, Camilla, et al.
Publicado: (2012)

Molecular Biomarkers in Drug-Induced Liver Injury: Challenges and Future Perspectives
por: Fu, Siyu, et al.
Publicado: (2020)

The Immunological Mechanisms and Immune-Based Biomarkers of Drug-Induced Liver Injury
por: Liu, Wenhui, et al.
Publicado: (2021)

The Study on the Mechanism of Hugan Tablets in Treating Drug-Induced Liver Injury Induced by Atorvastatin
por: Lv, Shujing, et al.
Publicado: (2021)

Drug‐induced cholestasis
por: Sundaram, Vinay, et al.
Publicado: (2017)

Metabolomic Profiling for Histologically Fibrotic Stage in Chronic Drug-Induced Liver Injury
por: He, Xian, et al.
Publicado: (2022)

Autoimmunity associates with severity of illness in elderly patients with drug-induced liver injury
por: Xiong, Yu-Ting, et al.
Publicado: (2023)

Identifying Drug-Induced Liver Injury Associated With Inflammation-Drug and Drug-Drug Interactions in Pharmacologic Treatments for COVID-19 by Bioinformatics and System Biology Analyses: The Role of Pregnane X Receptor
por: Huang, Jingjing, et al.
Publicado: (2022)

Comparison of Different Liver Test Thresholds for Drug-Induced Liver Injury: Updated RUCAM versus Other Methods
por: Yang, Hongyi, et al.
Publicado: (2019)

Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future
por: Danan, Gaby, et al.
Publicado: (2019)

Knowledge Mapping of Drug-Induced Liver Injury: A Scientometric Investigation (2010–2019)
por: Ke, Lixin, et al.
Publicado: (2020)

Immunotherapy and Gene Therapy: New Challenges in the Diagnosis and Management of Drug-Induced Liver Injury
por: Delire, Bénédicte, et al.
Publicado: (2022)

Study on the Characteristics of Small-Molecule Kinase Inhibitors-Related Drug-Induced Liver Injury
por: Dong, Huiqun, et al.
Publicado: (2022)

Correlation between serum cytokines and clinicopathological features in patients with drug-induced liver injury
por: Zhang, Yu, et al.
Publicado: (2022)

Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management
por: Li, Xichuan, et al.
Publicado: (2022)

Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury
por: Wang, Ming-Gui, et al.
Publicado: (2022)

Self-assembled FGF21 nanoparticles alleviate drug-induced acute liver injury
por: Huang, Zhiwei, et al.
Publicado: (2023)

Exploring BSEP inhibition-mediated toxicity with a mechanistic model of drug-induced liver injury
por: Woodhead, Jeffrey L., et al.
Publicado: (2014)

Predicting Drug-Induced Liver Injury Using Machine Learning on a Diverse Set of Predictors
por: Adeluwa, Temidayo, et al.
Publicado: (2021)

Baseline lymphocyte and cholinesterase levels may be the predictors of chronic herbal drug–induced liver injury
por: Zeng, Zhan, et al.
Publicado: (2022)

Efficacy and Safety of Corticosteroid Treatment in Patients With COVID-19: A Systematic Review and Meta-Analysis
por: Cheng, Wenwen, et al.
Publicado: (2020)

Psoralen Induced Liver Injury by Attenuating Liver Regenerative Capability
por: Zhou, Wang, et al.
Publicado: (2018)

The Characteristics, Prevalence, and Risk Factors of Drug-Induced Liver Injury Among Brucellosis Inpatients in Xinjiang, China
por: Tuohutaerbieke, Maermaer, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_deqm651v5sll9ls4272msjc8o0